A NEW ZEALAND doctor who sells stomach pain medicines says he has developed a new, effective drug to treat it.
Brio Internal Medicine said on Thursday it had approved the brio internal pill, named after the island’s native flora, which is prescribed to about 30,000 patients a year.
The pill contains the same active ingredient as a conventional pill but can be used by patients without symptoms of acid reflux, acid refractory colitis or other gastrointestinal disorders.
Dr John O’Neill said the drug could be made available within a few years, but it would need to go through a clinical trial.
“We will probably be able to get the drug into the market by 2019 or 2020,” he told ABC radio.
While it has not been tested in large numbers, Dr O’Neil said his team had received feedback from patients who were able to benefit from the new treatment.
One patient said she had experienced nausea and diarrhea after taking the pill for a month.
However, she has since stopped taking it.
Dr O’Donnell said the pill worked well and helped the stomach and intestines function more efficiently.
It was also a breakthrough for the pharmaceutical industry, which had been reluctant to invest in developing a new drug.
“This is a very innovative drug,” Dr Ollern said.
In February, an Australian health researcher, Dr Simon Pardew, who has worked with stomach ulcers and other digestive disorders, reported that he had developed a brio pill.
He said it could be a “game-changer” for the industry.
Other doctors, including a New Zealand gastroenterologist, have also been developing brio pills.